Redwood AI's Marketing Splurge Fails to Stem Losses as Quantum Dilution Fears Mount

Despite heavy PR spending of over $1M, Redwood AI shares dropped 20%+ in a week, closing at CAD 3.11. High volatility and pending Quantum.IQ acquisition with potential dilution add uncertainty.

Redwood AI is spending heavily to burnish its image, yet the stock continues to hemorrhage value. The company has shelled out $114,000 US to the InvestorBrandNetwork and an additional CAD 900,000 to Germany's MCS Market Communication Service GmbH for PR campaigns running through mid-2026. But the market is unimpressed. One report put the weekly decline at 20.26%, while another calculated a 22.25% rout over the same seven-day period.

The latest media push was driven by a June 10 article distributed via GlobeNewswire by AINewsWire, which touted Redwood AI as a leader at the intersection of artificial intelligence, public safety and post-quantum cybersecurity. The piece also flagged the company's planned takeover of Quantum.IQ, a Vancouver-based cybersecurity firm. Yet AINewsWire describes itself as a provider of financial marketing solutions, not a registered broker or analyst, and the report contained no new customer orders, deal closings or revenue figures. The disclosure identified it as paid advertising.

The disconnect between marketing spending and stock performance was stark on Wednesday. Redwood AI shares closed at CAD 3.11, down 8.26% on the day. The annualized 30-day volatility stands at a staggering 144.59%, underlining how sensitive the equity is to news flow and sentiment shifts.

Beyond the paid PR, there are tangible operational developments. In early May, the National Research Council of Canada approved up to CAD 240,000 in funding for the Q-SAFE project, which uses AI and quantum-based optimization to classify hazardous chemicals for defense and security applications. In April, Redwood AI sealed a two-year pilot program with Aidos Innovations to detect fentanyl and other opioids, involving the RCMP, Victoria police and the Canada Border Services Agency. Separately, a partnership with Resilience Biosciences aims to deploy AI for drug development.

The most consequential strategic move remains the proposed acquisition of Quantum.IQ. On May 28, Redwood signed a non-binding letter of intent. The terms carry significant implications for existing shareholders: up to 7 million shares upon closing and a further 7 million tied to milestones, for a total of 14 million new shares. With roughly 35.9 million shares currently outstanding, the potential dilution is material. The deal remains subject to due diligence, regulatory approval and the signing of definitive agreements.

Redwood also obtained clearance for electronic clearing in the United States, a move intended to broaden access for American investors. But the absence of binding commitments or concrete revenue streams leaves the company heavily dependent on narrative rather than performance.

Until the Quantum.IQ transaction closes or the company delivers meaningful sales, the combination of paid-for visibility and extreme volatility will likely keep investors on edge. The PR machine is running at full throttle, but the share price is telling a different story.